Patent details

EP3689913 Title: USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA

Basic Information

Publication number:
EP3689913
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP192109189
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA
French Title of Invention:
UTILISATION D'UN INHIBITEUR DE PCSK9 POUR TRAITER L'HYPERLIPIDÉMIE
German Title of Invention:
VERWENDUNG EINES PCSK9-INHIBITORS ZUR BEHANDLUNG VON HYPERLIPIDÄMIE
SPC Number:

Dates

Filing date:
10/10/2014
Grant date:
23/03/2022
EP Publication Date:
05/08/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/03/2022
EP B1 Publication Date:
23/03/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/10/2022
Expiration date:
10/10/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/03/2022
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Name:
Sanofi Biotechnology
Address:
54 rue La Boétie, 75008 Paris, France (FR)

Inventor

1

Name:
SCHWEMMER GIPE, Daniel A.
Address:
United States (US)

2

Name:
HANOTIN, Corinne
Address:
France (FR)

3

Name:
BESSAC, Laurence
Address:
France (FR)

4

Name:
SASIELA, William J.
Address:
United States (US)

5

Name:
BACCARA-DINET, Marie
Address:
France (FR)

6

Name:
CHAUDHARI, Umesh
Address:
United States (US)

7

Name:
PORDY, Robert C.
Address:
United States (US)

Priority

1

Priority Number:
201361890154 P
Priority Date:
11/10/2013
Priority Country:
United States (US)

2

Priority Number:
201461923103 P
Priority Date:
02/01/2014
Priority Country:
United States (US)

3

Priority Number:
201461955514 P
Priority Date:
19/03/2014
Priority Country:
United States (US)

4

Priority Number:
201462004620 P
Priority Date:
29/05/2014
Priority Country:
United States (US)

5

Priority Number:
201462025104 P
Priority Date:
16/07/2014
Priority Country:
United States (US)

6

Priority Number:
14306221
Priority Date:
31/07/2014
Priority Country:
European Patent Office (EPO) (EP)

7

Priority Number:
201462054571 P
Priority Date:
24/09/2014
Priority Country:
United States (US)

8

Priority Number:
14306584
Priority Date:
09/10/2014
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
C07K 16/40; A61K 39/395; A61P 3/06;

Publication

European Patent Bulletin

Issue number:
202212
Publication date:
23/03/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages